What is your experience with using oral deucravacitinib off label for conditions such as recalcitrant facial discoid lupus or recalcitrant lichen planus?
Do you have thoughts in general about the potential of TYK2 inhibition for these difficult to treat diseases?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
Community PollStarted
Do you utilize deucravacitinib for discoid lupus?
119 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Dermatology · UCONN
Answered on
This is an excellent question and importantly highlights the potential for newer therapies to help treat challenging diseases with few if any FDA approved options. In the case of DLE, I have found deucravacitinib to be a good option, sometimes as monotherapy or perhaps in conjunction with other topi...
Join for free or sign in to see the full answer